SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-029154
Filing Date
2023-08-14
Accepted
2023-08-11 20:38:18
Documents
7
Effectiveness Date
2023-08-14

Document Format Files

Seq Description Document Type Size
1 S-8 a082023s-8.htm S-8 68619
2 EX-FILING FEES ex107calculationoffilingfe.htm EX-FILING FEES 24957
3 EX-5 ex51legalopinions-8august2.htm EX-5 11730
4 EX-23.1 a231pricewaterhousecoopers.htm EX-23.1 2653
5 EX-99.1 ex991amendedandrestated201.htm EX-99.1 50226
6 EX-99.2 ex992anr2019inducementequi.htm EX-99.2 91357
7 image_0a.jpg GRAPHIC 8371
  Complete submission text file 0001628280-23-029154.txt   262307
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273960 | Film No.: 231165839
SIC: 2836 Biological Products, (No Diagnostic Substances)